The Role of Age in Subclinical Atherosclerosis in Asian People Living with Human Immunodeficiency Virus

被引:3
|
作者
Park, Sunghee [1 ]
Park, Se Yoon [2 ,3 ]
Lee, Eunjung [4 ]
Kim, Tae Hyong [4 ]
Lee, Eunyoung [5 ]
机构
[1] Soonchunhyang Univ, Bucheon Hosp, Dept Internal Med, Div Infect Dis, Bucheon, South Korea
[2] Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Hosp Med, Yongin, South Korea
[3] Yonsei Univ Hlth Syst, Yongin Severance Hosp, Ctr Digital Hlth, Yongin, South Korea
[4] Soonchunhyang Univ, Seoul Hosp, Dept Internal Med, Div Infect Dis, Seoul, South Korea
[5] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Div Infect Dis, Seoul, South Korea
关键词
HIV; Carotid intima-media thickness; Risk factors; Dyslipidemia; Cardiovascular disease; INTIMA-MEDIA THICKNESS; HIV-INFECTION; CARDIOVASCULAR-DISEASE; ANTIRETROVIRAL THERAPY; CAROTID VESSELS; RISK; ULTRASONOGRAPHY; PROGRESSION;
D O I
10.3947/ic.2022.0033
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: People living with human immunodeficiency virus (PLHIV) have an increased risk of atherosclerosis and cardiovascular disease, but specific guidance on when to suspect the onset of these diseases is limited. Materials and Methods: We aimed to identify cardiovascular risk factors in PLHIV using carotid intima-media thickness (IMT) through a cross-sectional, retrospective cohort study that enrolled 217 PLHIV who underwent carotid IMT measurement at a teaching hospital in Korea. We compared clinical characteristics between PLHIV with subclinical atherosclerosis and PLHIV with IMT within the normal range, and used a receiver operating characteristic curve to determine the cut-off age for predicting subclinical atherosclerosis. Results: Among the study population, 115 participants (53.0%) had subclinical atherosclerosis. In logistic regression, age and dyslipidemia were significantly associated with increased carotid IMT even after adjusting for other variables (odds ratio [OR]: 1.11, 95% confidence interval [CI]: 1.06 - 1.15, P <0.001; OR: 3.92, 95% CI: 1.87 - 8.22, P <0.001, respectively). The cut-off age for predicting subclinical atherosclerosis was 39.5 years (area under the curve 0.78, 95% CI: 0.72 - 0.84, P <0.001). Conclusion: Conventional risk factors including age and dyslipidemia were associated with subclinical atherosclerosis in Asian PLHIV. In particular, Asian PLHIV older than 40 years had an increased risk of subclinical atherosclerosis and may benefit from carotid IMT screening.
引用
收藏
页码:308 / 315
页数:8
相关论文
共 50 条
  • [1] Distinct Gut Microbiota Signatures Associated With Progression of Atherosclerosis in People Living With Human Immunodeficiency Virus
    Masia, Mar
    Garcia, Jose A.
    Garcia-Abellan, Javier
    Padilla, Sergio
    Fernandez-Gonzalez, Marta
    Agullo, Vanesa
    Gosalbes, Maria Jose
    Ruiz-Perez, Sonia
    Mascarell, Paula
    Botella, Angela
    Gutierrez, Felix
    JOURNAL OF INFECTIOUS DISEASES, 2024,
  • [2] Assessment of subclinical cardiac dysfunction by speckle-tracking echocardiography among people living with human immunodeficiency virus
    Liao, Chia-Te
    Toh, Han Siong
    Chang, Wei-Ting
    Yang, Chun-Ting
    Chen, Zhih-Cherng
    Tang, Hung-Jen
    Strong, Carol
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [3] Atherosclerosis in subjects newly diagnosed with human immunodeficiency virus infection
    Kirichenko, Tatiana V.
    Myasoedova, Veronika A.
    Shimonova, Tatiana E.
    Melnichenko, Alexandra A.
    Sviridov, Dmitri
    Sobenin, Igor A.
    Mazus, Alexey I.
    Orekhov, Alexander N.
    Bukrinsky, Michael I.
    BIOSCIENCE REPORTS, 2018, 38
  • [4] Effects of Exercise Training and Statin Use in People Living with Human Immunodeficiency Virus with Dyslipidemia
    Zanetti, Hugo Ribeiro
    Goncalves, Alexandre
    Paranhos Lopes, Leandro Teixeira
    Mendes, Edmar Lacerda
    Roever, Leonardo
    Silva-Vergara, Mario Leon
    Neves, Fernando Freitas
    Resende, Elmiro Santos
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2020, 52 (01) : 16 - 24
  • [5] Longitudinal Changes in Subclinical Vascular Disease in Ugandan Youth With Human Immunodeficiency Virus
    Dirajlal-Fargo, Sahera
    Zhao, Chenya
    Labbato, Danielle
    Sattar, Abdus
    Karungi, Christine
    Longenecker, Chris T.
    Nazzinda, Rashidah
    Funderburg, Nicholas
    Kityo, Cissy
    Musiime, Victor
    McComsey, Grace A.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E599 - E606
  • [6] Subclinical Atherosclerosis Imaging in People Living with HIV
    Schoepf, Isabella C.
    Buechel, Ronny R.
    Kovari, Helen
    Hammoud, Dima A.
    Tarr, Philip E.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
  • [7] Primary Prevention of Cardiovascular Disease for People Living with Human Immunodeficiency Virus
    Fox, Christopher B.
    Butler, Kristine
    Flynn, Devon
    NURSING CLINICS OF NORTH AMERICA, 2024, 59 (02) : 219 - 233
  • [8] Clinical factors and biomarkers associated with subclinical atherosclerosis in the human immunodeficiency virus infection
    Serrano-Villar, Sergio
    Estrada, Vicente
    Gomez-Garre, Dulcenombre
    Avila, Mario
    Fuentes-Ferrer, Manuel
    Sanchez-Parra, Clara
    Sainz, Talia
    de Carranza, Maria
    Fernandez-Cruz, Arturo
    MEDICINA CLINICA, 2012, 139 (06): : 231 - 237
  • [9] Menopausal Hormone Therapy and Subclinical Cardiovascular Disease in Women With and Without Human Immunodeficiency Virus
    Peters, Brandilyn A.
    Hanna, David B.
    Sharma, Anjali
    Anastos, Kathryn
    Hoover, Donald R.
    Shi, Qiuhu
    Moran, Caitlin A.
    Jackson, Elizabeth A.
    Alcaide, Maria L.
    Ofotokun, Igho
    Adimora, Adaora A.
    Haberlen, Sabina A.
    Cohen, Mardge
    Tien, Phyllis C.
    Michel, Katherine G.
    Levine, Steven R.
    Hodis, Howard N.
    Kaplan, Robert C.
    Yin, Michael T.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (03) : E661 - E670
  • [10] Current status of hepatitis C virus among people living with human immunodeficiency virus in Egypt
    Elsharkawy, Aisha
    Alem, Shereen Abdel
    Cordie, Ahmed
    Mohamed, Rahma
    Meshaal, Safa
    Esmat, Gamal
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2022, 116 (06) : 571 - 578